Lung transplantation can prolong survival for select patients with medically refractory, lung-limited, stage IV non-small cell lung cancer (NSCLC), according to ...
Targeted therapies may improve survival in these patients by concurrently managing immune dysregulation and the leukemic clone.
Researchers conducted a cross-sectional analysis of recent myeloma randomized clinical trials to evaluate the prevalence and characteristics of reporting spin in study findings.
In this systematic review, researchers aimed to analyze the uptake of breast cancer risk management strategies, including prophylactic mastectomy, intensive surveillance, or no active strategy, in ...
Investigators conducted a cross-sectional survey to identify factors associated with psychological hardship related to the cost of pediatric cancer care.
For 20 sites, men had increased odds of being diagnosed with cancer at regional and/or distant stages versus localized stage.
Patients exposed to vitamin D showed significantly longer treatment-free survival than nonusers, with median durations of 147 vs 82 months.
Detection of KRAS-mutant ctDNA by both NGS, ddPCR associated with shorter overall survival. HealthDay News — KRAS-mutant circulating tumor (ct)DNA is associated with worse overall survival (OS) in ...
Outpatient monitoring of CAR T-cell therapy reduces healthcare resource utilization and hospital days without impacting 30-day mortality, finds ASCO study.
Using individual patient data from phase 2 and 3 trials, investigators analyzed the value of pathologic complete response vs ctDNA clearance after neoadjuvant immunotherapy or perioperative ...
A real-world analysis investigates the impact of concurrent GLP-1 RA use on long-term survival and the safety profile of patients with solid and hematologic malignancies receiving immune checkpoint ...
In the phase 3 SUBITO trial, researchers aimed to compare outcomes with intensified alkylating chemotherapy to those with an HRD-targeting regimen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results